Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 16 studies | 34% ± 16% | |
peripheral blood | 14 studies | 31% ± 10% | |
intestine | 10 studies | 30% ± 17% | |
brain | 8 studies | 22% ± 5% | |
kidney | 7 studies | 29% ± 11% | |
liver | 7 studies | 33% ± 23% | |
lymph node | 6 studies | 31% ± 19% | |
pancreas | 5 studies | 41% ± 19% | |
bone marrow | 5 studies | 32% ± 8% | |
eye | 5 studies | 29% ± 12% | |
uterus | 5 studies | 33% ± 17% | |
placenta | 4 studies | 42% ± 20% | |
prostate | 4 studies | 29% ± 9% | |
breast | 4 studies | 28% ± 5% | |
adrenal gland | 3 studies | 24% ± 7% | |
skin | 3 studies | 21% ± 3% | |
thymus | 3 studies | 56% ± 29% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 1470.68 | 966 / 966 | 100% | 43.51 | 527 / 527 |
ovary | 100% | 1636.74 | 180 / 180 | 100% | 36.61 | 430 / 430 |
stomach | 100% | 1147.45 | 359 / 359 | 100% | 40.58 | 286 / 286 |
uterus | 100% | 1631.78 | 170 / 170 | 100% | 57.21 | 459 / 459 |
esophagus | 100% | 1589.40 | 1444 / 1445 | 100% | 47.47 | 183 / 183 |
brain | 100% | 1640.44 | 2639 / 2642 | 100% | 36.89 | 705 / 705 |
bladder | 100% | 1681.52 | 21 / 21 | 100% | 46.49 | 503 / 504 |
skin | 100% | 2190.96 | 1809 / 1809 | 100% | 37.13 | 471 / 472 |
breast | 100% | 1648.73 | 459 / 459 | 100% | 40.64 | 1115 / 1118 |
thymus | 100% | 1311.60 | 653 / 653 | 100% | 30.03 | 603 / 605 |
lung | 99% | 1390.99 | 575 / 578 | 100% | 40.42 | 1155 / 1155 |
prostate | 100% | 1443.19 | 245 / 245 | 99% | 24.64 | 499 / 502 |
kidney | 100% | 1351.90 | 89 / 89 | 97% | 18.11 | 878 / 901 |
pancreas | 97% | 701.59 | 319 / 328 | 99% | 33.02 | 177 / 178 |
adrenal gland | 100% | 1424.47 | 258 / 258 | 97% | 27.27 | 222 / 230 |
liver | 100% | 832.83 | 225 / 226 | 96% | 20.78 | 388 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 91.31 | 29 / 29 |
spleen | 100% | 1724.53 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 47.90 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 31.84 | 1 / 1 |
adipose | 100% | 1614.28 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1378.20 | 1332 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1238.80 | 801 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 25.22 | 78 / 80 |
heart | 97% | 886.50 | 831 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 48% | 1692.92 | 449 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000387 | Biological process | spliceosomal snRNP assembly |
GO_0036261 | Biological process | 7-methylguanosine cap hypermethylation |
GO_1903241 | Biological process | U2-type prespliceosome assembly |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0008380 | Biological process | RNA splicing |
GO_0000245 | Biological process | spliceosomal complex assembly |
GO_0046540 | Cellular component | U4/U6 x U5 tri-snRNP complex |
GO_0005686 | Cellular component | U2 snRNP |
GO_0000243 | Cellular component | commitment complex |
GO_0005685 | Cellular component | U1 snRNP |
GO_0005681 | Cellular component | spliceosomal complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0071007 | Cellular component | U2-type catalytic step 2 spliceosome |
GO_0071005 | Cellular component | U2-type precatalytic spliceosome |
GO_0034709 | Cellular component | methylosome |
GO_0034719 | Cellular component | SMN-Sm protein complex |
GO_0071011 | Cellular component | precatalytic spliceosome |
GO_0005829 | Cellular component | cytosol |
GO_0097526 | Cellular component | spliceosomal tri-snRNP complex |
GO_0005684 | Cellular component | U2-type spliceosomal complex |
GO_0005682 | Cellular component | U5 snRNP |
GO_0005687 | Cellular component | U4 snRNP |
GO_0034715 | Cellular component | pICln-Sm protein complex |
GO_0071013 | Cellular component | catalytic step 2 spliceosome |
GO_0030532 | Cellular component | small nuclear ribonucleoprotein complex |
GO_0005689 | Cellular component | U12-type spliceosomal complex |
GO_0005634 | Cellular component | nucleus |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SNRPD1 |
Protein name | Small nuclear ribonucleoprotein D1 polypeptide Small nuclear ribonucleoprotein Sm D1 (Sm-D1) (Sm-D autoantigen) (snRNP core protein D1) Small nuclear ribonucleoprotein Sm D1 (snRNP core protein D1) |
Synonyms | |
Description | FUNCTION: Plays a role in pre-mRNA splicing as a core component of the spliceosomal U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome . Component of both the pre-catalytic spliceosome B complex and activated spliceosome C complexes . As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs . May act as a charged protein scaffold to promote snRNP assembly or strengthen snRNP-snRNP interactions through non-specific electrostatic contacts with RNA . . FUNCTION: Plays a role in pre-mRNA splicing as a core component of the spliceosomal U1, U2, U4 and U5 small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. Component of both the pre-catalytic spliceosome B complex and activated spliceosome C complexes. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs. May act as a charged protein scaffold to promote snRNP assembly or strengthen snRNP-snRNP interactions through non-specific electrostatic contacts with RNA. . |
Accessions | ENST00000300413.10 ENST00000582475.1 P62314 J3QLR7 ENST00000579618.1 J3QLI9 Q7Z5A3 |